Under construction – not a live service
Sign in
Enrolling by invitationNo phase

TcPRF for Knee Osteoarthritis

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
National and Kapodistrian University of Athens
Trial code
NCT07351981
Record updated
20 January 2026
Original description
ObjectivesRead full original descriptionShow less

Randomized Double-Blind Study to Evaluate the Efficacy of Transcutaneous Pulsed Radiofrequency (PRF) Treatment for Knee Pain

Objectives

* Primary Objective: To evaluate the efficacy of transcutaneous PRF treatment in reducing knee pain compared to a sham intervention * Secondary Objectives: To assess the improvement in functional outcomes and patient satisfaction following PRF treatment.

Study Design

* Type: Randomized, double-blind, sham-controlled study. * Duration: 6 months * Study Population: Adults aged 40-75 years with chronic knee pain (lasting ≥ 6 months) due to osteoarthritis (OA). * How many patients in each group: 25 patients in each group (according to Janssens et al, 2024) Inclusion Criteria * Diagnosed with knee osteoarthritis according to NICE criteria. * Chronic knee pain (Visual Analogue Scale [VAS] ≥ 4). * Failure to respond adequately to conventional treatments (e.g., NSAIDs, physical therapy). * Willingness to comply with study procedures. Exclusion Criteria * Previous PRF/RF treatment for knee pain. * Hyaluronic acid injection for knee pain in the past 6 months * Knee surgery within the last 6 months. * Severe cardiovascular, neurological, or psychiatric conditions. * Active systemic infections or local skin infections at the knee. * Pregnancy or lactation.

Inclusion: Diagnosed with knee osteoarthritis according to NICE criteria; Chronic knee pain (Visual Analogue Scale [VAS] ≥ 4); Failure to respond adequately to conventional treatments (e.g., NSAIDs, physical therapy); Willingness to comply with study procedures. Exclusion Criteria; Previous PRF/RF treatment for knee pain; Hyaluronic acid injection for knee pain in the past 6 months; Knee surgery within the last 6 months; Severe cardiovascular, neurological, or psychiatric conditions; Active systemic infections or local skin infections at the knee; Pregnancy or lactation.

ClinicalTrials.gov NCT07351981